158 related articles for article (PubMed ID: 36787969)
1. Pulmonary artery compliance in different forms of pulmonary hypertension.
McCormick A; Krishnan A; Badesch D; Benza RL; Bull TM; De Marco T; Feldman J; Hemnes AR; Hirsch R; Horn E; Kennedy J; Mathai SC; McConnell W; Pugliese SC; Sager JS; Shlobin OA; Simon MA; Lammi MR
Heart; 2023 Jun; 109(14):1098-1105. PubMed ID: 36787969
[TBL] [Abstract][Full Text] [Related]
2. Right Ventricular Dyssynchrony in Patients With Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension.
Yamagata Y; Ikeda S; Kojima S; Ueno Y; Nakata T; Koga S; Ohno C; Yonekura T; Yoshimuta T; Minami T; Kawano H; Maemura K
Circ J; 2022 May; 86(6):936-944. PubMed ID: 35283366
[TBL] [Abstract][Full Text] [Related]
3. Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension.
MacKenzie Ross RV; Toshner MR; Soon E; Naeije R; Pepke-Zaba J
Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H259-64. PubMed ID: 23686712
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Insights from a referral center in Portugal.
Santos M; Gomes A; Cruz C; Rocha J; Ricardo M; Gonçalves F; Carvalho L; Vicente M; Melo A; Reis A
Rev Port Cardiol (Engl Ed); 2018 Sep; 37(9):749-757. PubMed ID: 30144959
[TBL] [Abstract][Full Text] [Related]
5. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
[No Abstract] [Full Text] [Related]
6. Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
Rajdev K; Lahan S; Wichman T
Int J Cardiol; 2021 Jun; 333():202-209. PubMed ID: 33621628
[TBL] [Abstract][Full Text] [Related]
7. Plasma markers in pulmonary hypertension subgroups correlate with patient survival.
Koudstaal T; van Uden D; van Hulst JAC; Heukels P; Bergen IM; Geenen LW; Baggen VJM; van den Bosch AE; van den Toorn LM; Chandoesing PP; Kool M; Boersma E; Hendriks RW; Boomars KA
Respir Res; 2021 May; 22(1):137. PubMed ID: 33947407
[TBL] [Abstract][Full Text] [Related]
8. Relationship between compliance and pulmonary vascular resistance in pulmonary arterial hypertension.
Guigui S; Zaidi SI; Lee JJ; Elajami T; Mihos CG; Escolar E
J Thorac Dis; 2020 May; 12(5):2971-2976. PubMed ID: 32642210
[TBL] [Abstract][Full Text] [Related]
9. Are pulmonary artery pulsatility indexes able to differentiate chronic pulmonary thromboembolism from pulmonary arterial hypertension? An echocardiographic and catheterization study.
Palecek T; Jansa P; Ambroz D; Hlubocka Z; Horak J; Skvarilova M; Aschermann M; Linhart A
Heart Vessels; 2011 Mar; 26(2):176-82. PubMed ID: 20953614
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
Wang Z; Li J; Wang X; Liu M; Liao M; Zhang C; Shang X
Ann Noninvasive Electrocardiol; 2022 Mar; 27(2):e12927. PubMed ID: 34908208
[TBL] [Abstract][Full Text] [Related]
11. Clinical Study of Acute Vasoreactivity Testing in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Xu QX; Yang YH; Geng J; Zhai ZG; Gong JN; Li JF; Tang X; Wang C
Chin Med J (Engl); 2017 Feb; 130(4):382-391. PubMed ID: 28218209
[TBL] [Abstract][Full Text] [Related]
12. Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.
Hoette S; Creuzé N; Rochitte CE; Simonneau G; Humbert M; Souza R; Chemla D
Pulmonology; 2019; 25(4):248-251. PubMed ID: 31080042
[TBL] [Abstract][Full Text] [Related]
13. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
Akizuki M; Sugimura K; Aoki T; Kakihana T; Tatebe S; Yamamoto S; Sato H; Satoh K; Shimokawa H; Kohzuki M
Respirology; 2020 Apr; 25(4):427-434. PubMed ID: 31261445
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
[TBL] [Abstract][Full Text] [Related]
16. Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension.
Nagel C; Benjamin N; Egenlauf B; Eichstaedt CA; Fischer C; Palevičiūtė E; Čelutkienė J; Harutyunova S; Mayer E; Nasereddin M; Marra AM; Grünig E; Guth S
Respiration; 2021; 100(5):369-378. PubMed ID: 33765679
[TBL] [Abstract][Full Text] [Related]
17. Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension: A cross-sectional study.
Nakamura H; Kato M; Nakaya T; Kono M; Tanimura S; Sato T; Fujieda Y; Oku K; Ohira H; Bohgaki T; Yasuda S; Tsujino I; Nishimura M; Atsumi T
Medicine (Baltimore); 2017 Oct; 96(43):e8349. PubMed ID: 29069014
[TBL] [Abstract][Full Text] [Related]
18. [Differences in hemodynamics of thromboembolic and primary pulmonary hypertension].
Polanowski T; Kurzyna M; Kuca P; Tomkowski W; Fijałkowska A; Kober J; Torbicki A
Pol Arch Med Wewn; 2000 Nov; 104(5):741-5. PubMed ID: 11434085
[TBL] [Abstract][Full Text] [Related]
19. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.
Tomaszewski M; Małkowska P; Sierawska O; Hrynkiewicz R; Mroczek E; Darocha S; Hymos A; Błaszczak P; Grywalska E; Niedźwiedzka-Rystwej P
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
